Abstract
Pain is one of the most significant causes of suffering and disability world-wide, and arguably the most burdensome global health challenge. The growing number of patients suffering from chronic pain conditions such as fibromyalgia, complex regional pain syndrome, migraine and irritable bowel syndrome, not only reflect the complexity and heterogeneity of pain types, but also our lack of understanding of the underlying mechanisms. Sensory neurons within the dorsal root ganglia (DRG) have emerged as viable targets for effective chronic pain therapy. However, DRG’s contain different classes of primary sensory neurons including pain-associated nociceptive neurons, non-nociceptive temperature sensing, mechanosensory and chemoreceptive neurons, as well as multiple types of immune and endothelial cells. This cell-population heterogeneity makes investigations of individual subgroups of DRG neurons, such as nociceptors, difficult. In attempts to overcome some of these difficulties, a limited number of immortalized DRG-derived cell lines have been generated over the past few decades. In vitro experiments using DRG-derived cell lines have been useful in understanding sensory neuron function. In addition to retaining phenotypic similarities to primary cultured DRG neurons, these cells offer greater suitability for high throughput assays due to ease of culture, maintenance, growth efficiency and cost-effectiveness. For accurate interpretation and translation of results it is critical, however, that phenotypic similarities and differences of DRG-derived cells lines are methodically compared to native neurons. Published reports to date show notable variability in how these DRG-derived cells are maintained and differentiated. Understanding the cellular and molecular differences stemming from different culture methods, is essential to validate past and future experiments, and enable these cells to be used to their full potential. This review describes currently available DRG-derived cell lines, their known sensory and nociceptor specific molecular profiles, and summarize their morphological features related to differentiation and neurite outgrowth.
Highlights
Cell bodies of sensory neurons are situated in dorsal root ganglia (DRG) or trigeminal ganglia (TG) and possess pseudounipolar processes that divide into two axons, one to innervate targets in the periphery, and the other projecting centrally in the spinal cord dorsal horn (DRG), or in the case of the trigeminal sensory nuclear complex, in the brain stem (TG)
While individual cell lines have in each instance been developed by individual investigators seeking desirable characteristics that lead to their use for a specific set of methodologies, there is significant scope for increasing the utilization of DRGderived cell lines in high-throughput screening tests investigating nociceptor targeted drug screens as well as basic nociceptor biology (Table 2)
ND7/23 cells for example have been mostly used for investigations of voltage gated sodium channel function, whereas F-11 cells are frequently used for investigations that involve neurite outgrowth and Ca2+-imaging (Table 2)
Summary
Anatomy & Histology, College of Medicine and Public Health, Flinders Health & Medical Research Institute, Flinders University, Adelaide, SA, Australia. Reviewed by: Tomokazu Tomo Fukuda, Iwate University, Japan Michael Fleischer, Essen University Hospital, Germany. Specialty section: This article was submitted to Cellular Neuropathology, a section of the journal
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.